.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Mawson Infrastructure
MIGI
Bitdeer Technologies
BTDR
MARA Holdings
MARA
BTCS Inc
BTCS
Abits
ABTS
US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 3.8700
- -0.2700-6.52%
Close Feb 27 16:00 ET
- 3.8700
- 0.00000.00%
Post 20:01 ET
41.35MMarket Cap-1.99P/E (TTM)
4.1398High3.8300Low33.86KVolume4.0400Open4.1400Pre Close134.78KTurnover0.35%Turnover RatioLossP/E (Static)10.69MShares5.870052wk High4.81P/B37.53MFloat Cap1.001052wk Low--Dividend TTM9.70MShs Float51.5000Historical High--Div YieldTTM7.48%Amplitude1.0010Historical Low3.9800Avg Price1Lot Size
Alterity Therapeutics Stock Forum
Sign in to post a comment
$Alterity Therapeutics (ATHE.US)$ Alterity Therapeutics has completed the first tranche of its placement by issuing 1,165,841,830 new ordinary fully paid shares at AUD 0.011 per share on February 17, 2025. The shares will be quoted on ASX under the code ATH.
A second tranche of 2,470,521,806 ordinary shares is pending shareholder approval, along with 1,212,121,212 options exercisable at AUD 0.028 with a 2-year expiry period. Upon completion of the first t...
A second tranche of 2,470,521,806 ordinary shares is pending shareholder approval, along with 1,212,121,212 options exercisable at AUD 0.028 with a 2-year expiry period. Upon completion of the first t...
4
$Alterity Therapeutics (ATHE.US)$
Alterity's Game-Changing MSA Treatment Gets A$40M Boost After 48% Disease Slowdown Results
Alterity's Game-Changing MSA Treatment Gets A$40M Boost After 48% Disease Slowdown Results
1
$Alterity Therapeutics (ATHE.US)$
Alterity Therapeutics Raises A$40.0 million in Placement
February 10, 2025 Alterity Therapeutics
– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –
– Capital raising was strongly supported by domestic and international institutional investors –
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 10 February 2025: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or the “Company”), a biotechnology company dedicated to...
Alterity Therapeutics Raises A$40.0 million in Placement
February 10, 2025 Alterity Therapeutics
– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –
– Capital raising was strongly supported by domestic and international institutional investors –
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 10 February 2025: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or the “Company”), a biotechnology company dedicated to...
7
16
$Alterity Therapeutics (ATHE.US)$
JPMorgan Chase & Co. and its affiliates have emerged as a substantial shareholder in Alterity Therapeutics, acquiring a 5.11% stake representing 272,198,215 ordinary shares as of February 3, 2025.
Between the news and trade halt, historic news release, expedited FDA approval track, and institutions buying in ...
something is cooking. predicting good news regarding FDA, so we're looking at a good ol pump.
watching close to determine target price. as of now I'm thi...
JPMorgan Chase & Co. and its affiliates have emerged as a substantial shareholder in Alterity Therapeutics, acquiring a 5.11% stake representing 272,198,215 ordinary shares as of February 3, 2025.
Between the news and trade halt, historic news release, expedited FDA approval track, and institutions buying in ...
something is cooking. predicting good news regarding FDA, so we're looking at a good ol pump.
watching close to determine target price. as of now I'm thi...
5
3
$Alterity Therapeutics (ATHE.US)$ Alterity Therapeutics Limited has reported a change in the voting interests held by The Bank of New York Mellon Corporation (BNYMC) and its affiliated entities. The BNYMC Group’s voting power in Alterity Therapeutics has increased from 39.55% to 41.28%, reflecting a shift in their stake within the company. This change signifies a notable increase in influence for the BNYMC Group within Alterity Therapeutics, potentially impacting future company decisions a...
1
$Alterity Therapeutics (ATHE.US)$ Holding my stock until they announce their ATH434-202 trial result. Stay strong guys ![]()
.
1
2
No comment yet
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
blessings u : 0.011,抢钱！
Trytosaveabit OP blessings u : True! but .011 X a billion is a lota money! Hehehe
blessings u Trytosaveabit OP : The current price is 4 kuai more. Such an issuance price is simply like the AK-47 shooting incident in a school.
睡不着的厨师 : Really trash.